Skip to main content
. 2015 Apr 16;10(4):e0124742. doi: 10.1371/journal.pone.0124742

Fig 5. Effects of levosimendan on eNOS (A) and iNOS activation (B) in hepatocytes subjected to peroxidation.

Fig 5

In A and B, densitometric analysis of p-eNOS and iNOS and an example of lanes taken in one of 5 different experiments performed for each experimental protocol. eNOS = endothelial nitric oxide isoform; iNOS = inducible nitric oxide isoform; L = levosimendan; NM = L-NAME. The other abbreviations are as in Figs 1–4. In A, b, d, e, f, g P <0.05 vs a; c, d, e, f, g P <0.05 vs b; d, e p<0.05 vs c; d, f, g P <0.05 vs e. In B, b, c, d, e, f, g P <0.05 vs a; c, d, e, f, g P <0.05 vs b; d, e P <0.05 vs c; d, f, g P <0.05 vs e. The results of densitometric analysis are expressed as means of 5 independent experiments (%) ± SD (indicated by the bars).